Pharmaniaga Berhad (Pharmaniaga) has selected Oracle Fusion Cloud Supply Chain & Manufacturing (SCM) to improve logistics processes in preparation for COVID-19 vaccine distribution in Malaysia. With Oracle Cloud SCM, Pharmaniaga can automate planning and execution processes and gain real-time shipment insights to improve its logistics operation's efficiency and security.
The largest integrated pharmaceutical group in Malaysia, Pharmaniaga needed a cloud-based logistics platform to automate manual processes and improve the traceability and security of its cold chain services.
“We’ve been delivering vaccines to health facilities in Malaysia for more than 25 years and have strong cold chain infrastructure, but we needed to reduce manual processes to meet the monumental challenge of distributing the COVID-19 vaccine. With Oracle Cloud SCM’s logistics and IoT applications, we will be better positioned to efficiently and safely deliver the COVID-19 vaccine across Malaysia,” said Abdul Malik Mohamed, Director of Logistics & Distribution, Pharmaniaga Berhad.
By offering solutions that enhance planning and real-time decision-making – such as Oracle Transportation Management and Oracle Internet of Things (IoT) Intelligent Applications – Oracle Cloud SCM helps customers identify new opportunities, rethink processes, plan and execute across the entire business. Implementing Oracle Transportation Management can enable Pharmaniaga to automate logistics planning and execution and improve efficiency. At the same time, Oracle IoT Intelligent Applications can help monitor cargo temperature and vehicle routes to validate the quality of products and enhance security.
“Unprecedented demand for the COVID-19 vaccine will create cold chain complexity unlike anything we’ve ever seen,” said Jasbir Singh, vice president, Software as a Service (SaaS), Oracle Malaysia. “Streamlining logistics processes and enhancing shipment tracking with Oracle Cloud SCM can enable Pharmaniaga to rise to this challenge and scale its operations to support the immunisation of Malaysia’s 32 million residents.”